NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inti Labs

Inti Labs

Private
TaiwanHealthcare & Life Scienceshttps://intilabs.com/

Last Round

Series A

Feb 1, 2025

Total Funding Raised

$14.63M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Inti Labs is a biotechnology company that develops advanced diagnostic services and testing solutions for the IVF process to improve fertility outcomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

IVF diagnosticsfertility testingendometrial receptivity testPGT-Aembryo screeningmicroRNA biomarkersoocyte quality assessmentfertility techreproductive medicinenon-invasive diagnosticspredictive fertility modelingfemtechAI fertilityclinical decision supportembryo transfer timing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inti Labs Comparables

Compare Inti Labs with similar companies based on industry and business-model similarity.

Inti Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Simbryo Technologies, Inc.
84%
Future Fertility
83%
Vitrolife AB
82%

Inti Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 1, 2025
SeedAug 11, 2022

Key People

Founding team and executive leadership

Barry Behr

Chief Technology Officer

Executive Team

Inti Labs Investors

Notable investors and investment history

Inti Labs investors
InvestorRounds
Taiwania CapitalSeries A
National Science and Technology CouncilSeed
Cathay VentureSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors grew 1224% MoM, from 34 to 450.

  • Jan 7, 2024

    Grew 18% QoQ, from 17 to 20 employees.

Inti Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inti Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inti Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersTaiwan
Employee Range22
Year Founded2022
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.